Search research articles
Contact Us
Filters
Showing results (91-100 of 138) with videos related to
Page
of 14
Sort By:
Neuro-Oncology Practice
|
August 7, 2019
Management of low-grade glioma: a systematic review and meta-analysis
Timothy J Brown, Daniela A Bota, Martin J van Den Bent, et al.
Histopathology
|
May 15, 2018
Spindle cell rhabdomyosarcoma of bone with FUS-TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype
Nooshi K Dashti, Rebecca N Wehrs, Brittany C Thomas, et al.
Neuro-Oncology Practice
|
December 8, 2015
Adult patients with supratentorial pilocytic astrocytoma: long-term follow-up of prospective multicenter clinical trial NCCTG-867251 (Alliance)
Paul D Brown, S Keith Anderson, Xiomara W Carrero, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 26, 2006
Central neurocytoma: management recommendations based on a 35-year experience
James L Leenstra, Fausto J Rodriguez, Christina M Frechette, et al.
Journal of Neuro-Oncology
|
September 16, 2005
Prospective study of quality of life in adults with newly diagnosed high-grade gliomas
Paul D Brown, Karla V Ballman, Teresa A Rummans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2006
Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials
Jan C Buckner, Karla V Ballman, John C Michalak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2013
Phase II study of bevacizumab in combination with sorafenib in recurrent glioblastoma (N0776): a north central cancer treatment group trial
Evanthia Galanis, S Keith Anderson, Jackie M Lafky, et al.
Journal of Neuro-Oncology
|
November 18, 2008
Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model
Gaspar J Kitange, Brett L Carlson, Ann C Mladek, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 20, 2004
Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma
Paul D Brown, Jan C Buckner, Judith R O'Fallon, et al.
Journal of Neuro-Oncology
|
May 24, 2019
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)
Kurt A Jaeckle, S K Anderson, Erin L Twohy, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 138) with videos related to
Sort By:
Page
of 14
Neuro-Oncology Practice
|
August 7, 2019
Management of low-grade glioma: a systematic review and meta-analysis
Timothy J Brown, Daniela A Bota, Martin J van Den Bent, et al.
Histopathology
|
May 15, 2018
Spindle cell rhabdomyosarcoma of bone with FUS-TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype
Nooshi K Dashti, Rebecca N Wehrs, Brittany C Thomas, et al.
Neuro-Oncology Practice
|
December 8, 2015
Adult patients with supratentorial pilocytic astrocytoma: long-term follow-up of prospective multicenter clinical trial NCCTG-867251 (Alliance)
Paul D Brown, S Keith Anderson, Xiomara W Carrero, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 26, 2006
Central neurocytoma: management recommendations based on a 35-year experience
James L Leenstra, Fausto J Rodriguez, Christina M Frechette, et al.
Journal of Neuro-Oncology
|
September 16, 2005
Prospective study of quality of life in adults with newly diagnosed high-grade gliomas
Paul D Brown, Karla V Ballman, Teresa A Rummans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2006
Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials
Jan C Buckner, Karla V Ballman, John C Michalak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2013
Phase II study of bevacizumab in combination with sorafenib in recurrent glioblastoma (N0776): a north central cancer treatment group trial
Evanthia Galanis, S Keith Anderson, Jackie M Lafky, et al.
Journal of Neuro-Oncology
|
November 18, 2008
Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model
Gaspar J Kitange, Brett L Carlson, Ann C Mladek, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 20, 2004
Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma
Paul D Brown, Jan C Buckner, Judith R O'Fallon, et al.
Journal of Neuro-Oncology
|
May 24, 2019
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)
Kurt A Jaeckle, S K Anderson, Erin L Twohy, et al.
Page
of 14